Memento Medicines
Developing biologic therapies for retinal diseases.
Biotechnology
📍 Boston, MA
Founded 2026
Current Valuation
Private
PRIVATE
Developing biologic therapies for retinal diseases. Headquartered in Boston, MA. Raised $93M in Series A funding in June 2026 led by Forbion.
Company Profile
Last Round
Series A — $93M (Jun 2026) · Lead: Forbion
Fundraising Status
Series A · $93M · this month
privateTotal raised $93M1 disclosed rounds
Funding History
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series A | $93M | Jun 2026 | Forbion | — |
Investors
Forbion · RA Capital Management · Avego BioScience Capital · Sanofi Ventures · Samsara BioCapital
BiotechnologyBiologicsRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.